These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23580933)

  • 1. Formulation and optimisation of raft-forming chewable tablets containing H2 antagonist.
    Prajapati ST; Mehta AP; Modhia IP; Patel CN
    Int J Pharm Investig; 2012 Oct; 2(4):176-82. PubMed ID: 23580933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation, optimization, and evaluation of raft-forming formulations containing Nizatidine.
    Darwish MKM; Abu El-Enin ASM; Mohammed KHA
    Drug Dev Ind Pharm; 2019 Apr; 45(4):651-663. PubMed ID: 30638411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux.
    Mandel KG; Daggy BP; Brodie DA; Jacoby HI
    Aliment Pharmacol Ther; 2000 Jun; 14(6):669-90. PubMed ID: 10848650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers.
    Bunlung S; Nualnoi T; Issarachot O; Wiwattanapatapee R
    Saudi Pharm J; 2021 Oct; 29(10):1143-1154. PubMed ID: 34703368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and evaluation of famotidine floating tablets.
    Jaimini M; Rana AC; Tanwar YS
    Curr Drug Deliv; 2007 Jan; 4(1):51-5. PubMed ID: 17269917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.
    Tytgat GN; Simoneau G
    Aliment Pharmacol Ther; 2006 Mar; 23(6):759-65. PubMed ID: 16556178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study on the raft chemical properties of various alginate antacid raft-forming products.
    Dettmar PW; Gil-Gonzalez D; Fisher J; Flint L; Rainforth D; Moreno-Herrera A; Potts M
    Drug Dev Ind Pharm; 2018 Jan; 44(1):30-39. PubMed ID: 28836872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of processing and formulation variables on the stability of a salt of a weakly basic drug candidate.
    Badawy S; Vickery R; Shah K; Hussain M
    Pharm Dev Technol; 2004 Aug; 9(3):239-45. PubMed ID: 15458230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 3(2) full factorial design.
    Boldhane SP; Kuchekar BS
    Curr Drug Deliv; 2009 Oct; 6(5):477-85. PubMed ID: 19863493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and pharmacokinetic evaluation of alginate-pectin polymeric rafts forming tablets using box behnken design.
    Abbas G; Hanif M
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2026-2037. PubMed ID: 30084289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation, development and in vitro characterization of modified release tablets of capecitabine.
    Gaikwad SS; Avhad RD; Kalkotwar RS
    Drug Dev Ind Pharm; 2020 Jan; 46(1):20-30. PubMed ID: 31778085
    [No Abstract]   [Full Text] [Related]  

  • 12. Formulation and evaluation of mixed matrix gastro-retentive drug delivery for famotidine.
    Patel DM; Patel MJ; Patel AN; Patel CN
    Int J Pharm Investig; 2011 Oct; 1(4):247-54. PubMed ID: 23071951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
    Alsarra IA; El-Bagory I; Bayomi MA
    Drug Dev Ind Pharm; 2005 May; 31(4-5):385-95. PubMed ID: 16093204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chewable Tablets of Acacia catechu Extract, an Alternative to Betel (Paan) for Mouth Ulcers: Formulation and In vitro Evaluation.
    Bhardwaj P; Shailendra K; Sharma DS; Sharma A; Kulkarni MP; Singh SK; Singh VP; Singh G; Kumar P; Kumar R
    Curr Drug Deliv; 2021; 18(4):500-512. PubMed ID: 32723271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and optimization of orodispersible tablets of diazepam.
    Abed KK; Hussein AA; Ghareeb MM; Abdulrasool AA
    AAPS PharmSciTech; 2010 Mar; 11(1):356-61. PubMed ID: 20232267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of effervescent floating tablets based on hydroxyethyl cellulose and sodium alginate using pentoxifylline as a model drug.
    Rahim SA; Carter PA; Elkordy AA
    Drug Des Devel Ther; 2015; 9():1843-57. PubMed ID: 25848220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of floating tablet of H2-receptor antagonist.
    Kesarla RS; Vora PA; Sridhar BK; Patel G; Omri A
    Drug Dev Ind Pharm; 2015; 41(9):1499-511. PubMed ID: 25243639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation development of sugar free antacid chewable tablets for diabetes induced acidity in patients.
    Khan M; Rehman H; Ayaz S; Qamar F; Owais A; Sana A; Naveed S
    Pak J Pharm Sci; 2019 Nov; 32(6(Supplementary)):2811-2816. PubMed ID: 32024618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of pH-responsive alginate raft formulation of risedronate for reduced esophageal irritation.
    Jang SW; Lee JW; Ryu DS; Son M; Kang MJ
    Int J Biol Macromol; 2014 Sep; 70():174-8. PubMed ID: 24995633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents.
    Quartarone G
    Minerva Ginecol; 2013 Oct; 65(5):541-9. PubMed ID: 24096290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.